These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


476 related items for PubMed ID: 28502157

  • 1. Study of Serum Immunoglobulin Levels and T lymphocyte Subsets in Children with Beta Thalassemia with Iron Overload in Egypt.
    Hagag AA, Elgamasy MA, Abd Elbar ES.
    Egypt J Immunol; 2016 Jan; 23(1):97-105. PubMed ID: 28502157
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM, Abdel-Salam A, Farhan MS, Ragab R.
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thyroid Function in Egyptian Children with Sickle Cell Anemia in Correlation with Iron Load.
    Hagag AA, El-Asy HM, Badraia IM, Hablas NM, El-Latif AEA.
    Endocr Metab Immune Disord Drug Targets; 2019 Oct; 19(1):46-52. PubMed ID: 30207251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients.
    Al-Awadhi AM, Alfadhli SM, Al-Khaldi D, Borhama M, Borusly M.
    Int J Lab Hematol; 2010 Apr; 32(2):191-6. PubMed ID: 19453575
    [Abstract] [Full Text] [Related]

  • 10. Study of serum hepcidin in hereditary hemolytic anemias.
    El Beshlawy A, Alaraby I, Abdel Kader MS, Ahmed DH, Abdelrahman HE.
    Hemoglobin; 2012 Apr; 36(6):555-70. PubMed ID: 23088733
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Unbalanced bone turnover in children with beta-thalassemia.
    Salama OS, Al-Tonbary YA, Shahin RA, Eldeen OA.
    Hematology; 2006 Jun; 11(3):197-202. PubMed ID: 17325962
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic value of combined therapy with deferiprone and silymarin as iron chelators in Egyptian children with beta thalassemia major.
    Hagag AA, Elfaragy MS, Elrifaey SM, Abd El-Lateef AE.
    Infect Disord Drug Targets; 2015 Jun; 15(3):189-95. PubMed ID: 26239735
    [Abstract] [Full Text] [Related]

  • 15. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A, El-Ghamrawy M, EL-Ela MA, Said F, Adolf S, Abdel-Razek AR, Magdy RI, Abdel-Salam A.
    Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pulmonary functions in Egyptian children with transfusion-dependent β-thalassemia.
    Abd El Hakeem AA, Mousa SMO, AbdelFattah MT, AbdelAziz AO, Abd El Azeim SS.
    Transfus Med; 2019 Feb; 29(1):55-60. PubMed ID: 30779248
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Major Depression in Children with Transfusion-Dependent Thalassemia Is Strongly Associated with the Combined Effects of Blood Transfusion Rate, Iron Overload, and Increased Pro-inflammatory Cytokines.
    Al-Hakeim HK, Najm AH, Al-Dujaili AH, Maes M.
    Neurotox Res; 2020 Jun; 38(1):228-241. PubMed ID: 32335809
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.